baber/WOPTO huggingface dataset:
Patent DK-0566711-T3 (DK)
Inventor: GLANG SIEGFRIED
IPC: E21D11/00
Filed: 1992-10-10
Granted: 1995-12-18
Abstract: PCT No. PCT/DE92/00860 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Oct. 10, 1992 PCT Pub. No. WO93/08370 PCT Pub. Date Apr. 29, 1993.The invention relates to a shield tail sealing (7) for driving shields consisting of a basic body (2) made of elastomeric material and having a substantially rectangular cross section in the longitudinal direction and being inclined against the driving direction, whereby a sealing nose (12) is formed by molding at its sliding end on the inner side (inner side 11), which nose, in the operating condition, elastically presses against the outer side (4) of the tunnel lining, as well as a holding means (8) extending substantially contrally in the basic body (2), said means being fastened on a mounting support (10) arranged on the shield tail (9). The essence of said invention is that in the upper zone adjacent to the shield tail (9), the basic body (2) has on the outer side (outer side 13) at least one sealing lip ( 14 ) of which the nose (18 ) , in the installed condition, projects beyond the outer surface (19) of the shield tail (9) or jacket of the shield.
Patent DK-0642585-T3 (DK)
Inventor: GODOWSKI PAUL J
IPC: C07K19/00
Filed: 1993-05-17
Granted: 2006-05-15
Abstract: The invention concerns a method for activating receptors selected from receptor tyrosine kinases, cytokine receptors and members of the nerve growth factor receptor superfamily. A conjugate comprising the direct fusion of at least two ligands capable of binding to the receptor(s) to be activated is contacted with the receptors, whereby the ligands bind their respective receptors inducing receptor oligomerization.
Patent DK-0610467-T3 (DK)
Inventor: BABLED RAYMOND
IPC: A61F6/00
Filed: 1993-07-20
Granted: 1999-09-20
Abstract: PCT No. PCT/FR93/00737 Sec. 371 Date Apr. 21, 1994 Sec. 102(e) Date Apr. 21, 1994 PCT Filed Jul. 20, 1993 PCT Pub. No. WO94/05237 PCT Pub. Date Mar. 17, 1994.Securing and protective rigid disc for a condom, having on its peripheral edge a flat flange 1 provided to be engaged under the bead B of the sheath of condom P, said disc being placed on the upper and outside end of the condom. The flange 1 surrounds a part of the disc which, towards the outside, presents a protrusion above the plane of said flange. This protrusion preferably comprises a skirt 2 serving of lateral backing for the bead of the sheath and surrounding a convex dom 3, for example of spherical shape. This disc can be used with all kind of condoms.
Patent DK-0644873-T3 (DK)
Inventor: FREI JOERG
IPC: A61P33/02
Filed: 1994-04-02
Granted: 1997-04-07
Abstract: PCT No. PCT/EP94/01036 Sec. 371 Date Dec. 12, 1994 Sec. 102(e) Date Dec. 12, 1994 PCT Filed Apr. 2, 1994 PCT Pub. No. WO94/24094 PCT Pub. Date Oct. 27, 1994   <IMAGE>  (I)  Compounds of formula (I) in which (a) four of the radicals R1, R2, R3, R4, R5 and R6 are hydrogen and the others independently of one another are in each case C1-C2alkyl, these groups being bonded to the same carbon atom or to two different carbon atoms, or (b) five of the radicals R1, R2, R3, R4, R5 and R6 are hydrogen and the other radical is C1-C2alkyl or hydroxymethyl, or salts thereof, are described. The compounds of formula (I) and their salts are ornithine decarboxylase inhibitors.
Patent DK-0720471-T3 (DK)
Inventor: ANDRIANOV ALEXANDER K
IPC: A61K9/16
Filed: 1994-09-21
Granted: 2001-05-07
Abstract: A method for the preparation of microparticles, and the product thereof, that includes dispersing a substantially water insoluble non-ionic or ionic polymer in an aqueous solution in which the substance to be delivered is also dissolved, dispersed or suspended, and then coagulating the polymer together with the substance by impact forces to form a microparticle. In an alternative embodiment, the microparticle is formed by coagulation of an aqueous polymeric dispersion through the use of electrolytes, pH changes, organic solvents in low concentrations (the minimal amount necessary to break up the dispersion), or temperature changes to form polymer matrices encapsulating biological materials.
Patent DK-0784452-T3 (DK)
Inventor: SUSLOV NIKOLAI
IPC: A61B18/00
Filed: 1994-08-29
Granted: 2004-02-16
Abstract: PCT No. PCT/SE94/00790 Sec. 371 Date May 20, 1997 Sec. 102(e) Date May 20, 1997 PCT Filed Aug. 29, 1994 PCT Pub. No. WO96/06572 PCT Pub. Date Mar. 7, 1996An electrosurgical device employs a pencil-shaped instrument having a conductive tip formed of high melting point material such as zirconium or hafnium connected to the positive terminal of a high frequency generator and having a nozzle at the end for the passage of a gas from a supply to create a plasma at the nozzle end when placed on the patient to stop bleeding.
Patent DK-0669100-T3 (DK)
Inventor: HABISON GEORG DR
IPC: B05B7/06
Filed: 1995-02-22
Granted: 1999-08-02
Abstract: The applicator has a one-piece component (1) with supply passages (8, 9) for the components leading from the union end (2) to the discharge end, together with a passage (13, 14) for medicinal gas spraying the components. All passages have separate outlets (10, 11, 15) in the face of the discharge end. For part at least of their length the component passages are enclosed by a common gas passage (14) immediately before their outlets. All passages can be parallel immediately before their outlets, while the enclosing part of the gas passage can be annular. The component outlets can be flush with that of the gas, or preferably set back from it. There can be a separate external component enclosing the annular passage and which is adjustable in the lengthwise direction.
Patent DK-0733003-T3 (DK)
Inventor: HOENERSCH KLAUS
IPC: B62D33/04
Filed: 1994-12-19
Granted: 1998-03-02
Abstract: PCT No. PCT/EP94/04224 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed Dec. 19, 1994 PCT Pub. No. WO95/17319 PCT Pub. Date Jun. 29, 1995A vehicle with superstructure is used to transport containers, boxes or other loads, especially beverage crates. Several loading boxes are directly or indirectly secured on both sides to a central support arranged in the upper region of the superstructure and run in the longitudinal direction of the vehicle, whereby at least part of the loading boxes can be raised or lowered by lifting devices and the loading boxes are fitted on a raisable and lowerable holding device.
Patent DK-0740706-T3 (DK)
Inventor: KUNZ MARKWART
IPC: C12N15/09
Filed: 1995-01-18
Granted: 2006-02-13
Abstract: The invention relates to sucrose isomerases, to DNA sequences coding therefor, and to novel processes for the production of non-cariogenic sugars.
Patent DK-0750506-T3 (DK)
Inventor: SELSTED MICHAEL E
IPC: A23L3/3526
Filed: 1995-02-10
Granted: 2001-05-07
Abstract: The present invention provides indolicidin analogs, which are tryptophan-rich peptides that have substantially the same amino acid sequence as naturally occurring indolicidin, exhibit broad spectrum antimicrobial activity and have antimicrobial selectivity as compared to naturally occurring indolicidin. The invention also provides methods of using an indolicidin analog to inhibit or prevent the survival or growth of a microorganism in an environment capable of sustaining such survival or growth. The invention provides, for example, methods of administering an effective amount of an indolicidin analog to an environment capable of sustaining the survival or growth of a microorganism.
Patent DK-0782450-T3 (DK)
Inventor: RADLMAIER ALBERT
IPC: A61P5/32
Filed: 1995-09-22
Granted: 2003-08-18
Abstract: PCT No. PCT/EP95/03733 Sec. 371 Date Jun. 13, 1997 Sec. 102(e) Date Jun. 13, 1997 PCT Filed Sep. 22, 1995 PCT Pub. No. WO96/09057 PCT Pub. Date Mar. 28, 1996Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of aromatase inhibitors to men experiencing male menopause can remedy the relative androgen deficiency in men while at the same time approximating the physiological hormonal ratio of androgens to estrogens.
Patent DK-0711751-T3 (DK)
Inventor: MATTHEWS IAN RICHARD
IPC: A01N47/22
Filed: 1992-09-09
Granted: 2000-04-10
Abstract: Fungicidal compounds having the formula (I): <CHEM> wherein W is CH3O.CH=CCO2CH3, CH3ON=CCONR<3>R<4> or CH3ON=CCO2CH3 and stereoisomers thereof; n is O or 1; X is oxygen or sulphur; Z is oxygen, sulphur or NR<1>; R<1> is hydrogen or alkyl optionally substituted with halogen, C1-6 alkoxy, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl or aryl; R<2> is alkyl, haloalkyl, alkenyl, alkynyl, alkoxycarbonyl(C1-4)alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aryl(C1-4)alkyl, optionally substituted heteroaryl(C1-4)alkyl, optionally substituted aryloxy(C1-4)alkyl, optionally substituted heteroaryloxy(C1-4)alkyl, optionally substituted aryloxy(C2-4)alkenyl, optionally substituted heteroaryloxy(C2-4)alkenyl, optionally substituted aryl(C2-4)alkenyl, optionally substituted heteroaryl(C2-4)alkenyl, optionally substituted arylcarbonyl(C1-4)alkyl, optionally substituted heteroarylcarbonyl(C1-4)alkyl, optionally substituted aryloxycarbonyl(C1-4)alkyl, optionally substituted heteroaryloxycarbonyl-(C1-4)alkyl or -COR<5>; or R<1> and R<2> together form an optionally substituted 4-, 5- or 6-membered heterocyclic ring system; R<3> and R<4> are independently hydrogen or methyl; and R<5> is optionally substituted heteroaryl or optionally substituted aryl; and processes for preparing, compositions comprising and methods of combating fungi using compounds of formula (I). Also provided is a process for the preparation of a compound of formula (XX): <CHEM> wherein p is 0 or 1.
Patent DK-0773782-T3 (DK)
Inventor: BATTISTINI CARLO
IPC: A61K31/4178
Filed: 1996-04-23
Granted: 2001-06-25
Abstract: The present invention relates to terpenoidic derivatives, known in the art as Sarcodictyins, for use as therapeutic agents, and to pharmaceutical compositions containing them. In particular, Sarcodictyins can be useful as therapeutic antineoplastic agents in the treatment of cancers in human or animal beings.
Patent DK-0865492-T3 (DK)
Inventor: OSBOURN JANE KATHARINE
IPC: C07K19/00
Filed: 1996-12-09
Granted: 2001-06-11
Abstract: Sequence and binding information is provided for particularly advantageous specific binding members which bind human carcinoembryonic antigen (CEA) with a dissociation constant which is less than 1,0 x 10<-8>M, are substantially non-cross-reactive with human liver cells, bind to the A3-B3 extracellular domain of human carcinoembryonic antigen and/or bind to cell-associated human carcinoembryonic antigen preferentially over soluble human carcinoembryonic antigen. These are useful particularly in determination of CEA expression by cells such as tumour cells.
Patent DK-0886474-T3 (DK)
Inventor: WILLIBALD-ETTLE INGRID
IPC: A23L27/30
Filed: 1997-02-21
Granted: 2001-10-01
Abstract: The invention relates to confections, in particular hard and soft confections, which contain a sweetener of 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS), in particular 6-O-alpha-D-glucopyranosyl-D-sorbitol (1,6 GPS), 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS) and 1-O-alpha-D-glucopyranosyl-D-mannitol (1,1 GPM); and to the use of this sweetener in confections, in particular pharmaceutically active confections.
Patent DK-0935652-T3 (DK)
Inventor: NARHI LINDA OWENS
IPC: C12N1/21
Filed: 1997-10-15
Granted: 2004-07-26
Abstract: The present invention concerns variants and chemical derivatives of keratinocyte growth factor-2 (KGF-2) protein. Also disclosed are nucleic acid molecules encoding such variants, as well as methods for using such variants and chemical derivatives to stimulate epithelial cell proliferation.
Patent DK-0971707-T3 (DK)
Inventor: LUKACS KAROLY
IPC: A61K36/28
Filed: 1997-04-04
Granted: 2003-03-03
Abstract: The invention relates to compositions for treating burns and external ulcers containing as active ingredient the mixture of one or more sulfonamides, a macrolide antibiotic or chloramphenicol or thiamphenicol, together with zinc oxide, camomile oil and azulene.
Patent DK-0892643-T3 (DK)
Inventor: LARSEN CHRISTIAN P
IPC: A61P37/06
Filed: 1997-03-20
Granted: 2002-10-14
Abstract: The present invention provides a method for inhibiting an immune response and a method for inhibiting rejection of transplanted tissues. This method comprises preventing an endogenous molecule on a cell selected from the group consisting of gp39 and CD40 antigens from binding its endogenous ligand and preventing an endogenous molecule on a cell selected from the group consisting of CTLA4, CD28, and B7 antigens from binding its endogenous ligand. The prevention of such molecules from binding their ligand thereby blocks two independent signal pathways and inhibits the immune response resulting in transplanted tissue rejection.
Patent DK-0891511-T3 (DK)
Inventor: HAUTALA REIJO
IPC: F16L59/16
Filed: 1997-04-14
Granted: 2003-09-22
Abstract: The invention relates to a fastening arrangement for sequentially interconnecting tube portions (1) comprising nested tubes (2, 3). The joint comprises a conical portion (5) for receiving an external locking band (6). Said conical portion (5) comprises a portion of insulating material extending inwards beyond an outer tube (3) into an insulating space between said tubes (2, 3). Separate supporting means (15, 16, 19) for said insulating material are associated with said conical portion (5). The invention further relates to a method for securing the stability of nested tubes (2, 3) in connection with a tube system comprising modular tube pieces (1) each of which comprises an inner tube (2), an outer tube (3) as well as at least partially conical end pieces located at the ends of said tubes and comprising, as such, an insulating portion. A separate supporting ring (19) is arranged at the insulating portion of said end pieces and said outer tube (3) is attached using a fastener (18) extending to behind a plane constituted by an extension of said supporting ring (19).
Patent DK-0963200-T3 (DK)
Inventor: D AMATO ROBERT J
IPC: A61K31/192
Filed: 1997-11-04
Granted: 2005-10-24
Abstract: The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Additionally, anti-inflammatory drugs, such as steroids and NSAIDs can inhibit angiogenesis dependent diseases either alone or in combination with thalidomide and related compounds. Importantly, these compounds can be administered orally.
Patent DK-0869192-T3 (DK)
Inventor: JANSEN WOLFGANG
IPC: C22B7/00
Filed: 1998-04-01
Granted: 2001-11-12
Abstract: Recovery of non-ferrous metals from objects (38) consisting of or containing both ferrous and non-ferrous materials takes place comprises heating such objects to a separation temperature which lies between the melting points of the ferrous and non-ferrous materials, and collecting the molten non-ferrous material. The objects (38) are transported continuously, without preliminary comminution, through a tunnel furnace (1), which is provided with an appropriate transport system (35) and are heated there to a separation temperature, with collection of the resulting molten non-ferrous material.
Patent DK-0885836-T3 (DK)
Inventor: COTTINEAU JEAN
IPC: B62D33/06
Filed: 1998-06-05
Granted: 2003-05-05
Abstract: The truck comprises a self-propelled wheeled chassis with a cab (4) containing controls (5) and an engine (6). The engine is protected by a hinged top cover (7) which supports the operator's seat (8). When the engine cover is raised to give access to the engine the operator's seat projects through a rear opening in the cab which is normally covered by a hinged glazed panel (10). When the panel (10) is opened, with the aid of pneumatic cylinders (12), it passes mainly inside the top of the cab, leaving the aperture free to accommodate the seat.
Patent DK-0903016-T3 (DK)
Inventor: OZLUTURK FATIH
IPC: H04B7/26
Filed: 1998-03-10
Granted: 2005-01-10
Abstract: A subscriber unit comprising controller means (2330) for storing a program received by the subscriber unit in first memory means (2332) and for determining whether the program was received correctly; the controller means (2330), on a condition that the program was received correctly, storing the program in a second memory means (2332); and the controller means (2330) rebooting the subscriber unit and loading the program.
Patent DK-1006053-T3 (DK)
Inventor: SAUER REINER DR
IPC: B65D43/02
Filed: 1999-07-22
Granted: 2002-10-21
Abstract: A can has a lid (1) with a closure (2) consisting of a ring which is hot sealed to the can blank, and a die-cut surrounding metal part and which is double-folded onto the can. The can ring closure is removed be peeling using an opening tab and replaced by hand pressure.
Patent DK-1124672-T3 (DK)
Inventor: CARPENTER CHARLES THOMAS
IPC: B27L11/02
Filed: 1999-10-27
Granted: 2005-12-12
Abstract: A chip and method for producing wood pulp. First, second and third pairs of substantially parallel sides are formed by cleaving, cutting and cutting, respectively. The sides of the second pair of sides are cut by a first knife so as to be spaced between about 2 to 8 mm. The sides of the third pair of sides are cut by a second knife so as to be spaced a greater distance apart than the first pair. The sides of the first pair of sides are cleaved substantially along the grain direction so as to be spaced also a greater distance apart than the sides of the first pair. The sides of the third pair of sides are cut so as to be substantially perpendicular to the sides of the first pair of sides.
Patent ES-2174794-T3 (ES)
Inventor: OVERKLEEFT HERMAN STEVEN
IPC: A61P35/00
Filed: 2000-02-03
Granted: 2002-11-16
Abstract: The invention pertains to novel peptide analogues suitable for inhibiting protein:prenyl transferased. The analogues comply with the following formula: <CHEM>  in which:     R<1> is hydrogen or a thiol-protecting group;   R<2> and R<3> are independently hydrogen or C1-C4 alkyl;   R<4> is hydrogen, C1-C4 alkyl, C1-C4 acyl or peptidyl;   R<5> is hydrogen or C1-C4 alkyl;   R<6> is hydrogen or optionally substituted C1-C6 alkyl; A is a direct bond or an optionally substituted C1-C4 alkylene chain;     Y represents an oxo group or two hydrogen atoms;   Z is oxygen, sulphur, imino or C1-C8 alkyl-, aryl- or acylimino;   m is 0, 1 or 2; n is 0 or 1.el
Patent ES-2199771-T3 (ES)
Inventor: ORTMANN ULRICH F
IPC: F27D9/00
Filed: 2000-02-16
Granted: 2004-03-01
Abstract: The invention relates to a casting chamber, especially for die-casting metal, comprising an outer shell (2) and an inner cylinder (3) which is placed in said outer shell (2) and connected thereto, especially with a shrink fit. The invention is characterised in that at least one coolant channel (5, 9, 11) is configured between the outer shell (2) and the inner cylinder (3), said coolant channel extending over at least part of the axial length of the casting chamber (1).
Patent ES-2269101-T3 (ES)
Inventor: CHOWDHURY SHAFIQUL I
IPC: C12N15/869
Filed: 2000-01-18
Granted: 2007-04-01
Abstract: A safe live recombinant virus as well as a vaccine is produced by the deletion of a portion of the native glycoprotein E (gE) coding region of bovine herpesvirus 1 (BHV-1) followed by the insertion of a plasmid including a foreign functional beta-gal at the gE locus. The deletion of gE gene stably attenuates the virus and serves as an immunological marker differentiating vaccinated animals from infected animals. Moreover, production of beta-gal allows easy assessment of gEDELTA3.1IBRbeta virus replication in vaccinated animals and serves as a phenotypic marker which distinguishes it from wild type virus replication in infected animals.
Patent ES-2262505-T3 (ES)
Title: Empleo de esteres de alcamolaminas de acidos grasos.
Inventor: MILAN SERGIO
IPC: C08K5/17
Filed: 2000-01-22
Granted: 2006-12-01
Abstract: Empleo de composiciones que contienen, al menos, un éster de alcanolamina de ácido graso elegido entre el grupo de los ésteres de las alcanolaminas de los ácidos grasos de la fórmula (II) en la que R1CO significa un resto acilo con 6 hasta 22 átomos de carbono, R2 significa hidrógeno o R1CO, R4 significa un resto alquilo con 1 hasta 4 átomos de carbono y m y n significan, en suma, 0 o números desde 1 hasta 12, y los ésteres de alcanolaminas de los ácidos grasos de la fórmula (III) en la que R1CO significa un resto acilo con 6 hasta 22 átomos de carbono, R2 significa hidrógeno o R1CO, R4 y R5 significan, independientemente entre sí, restos alquilo con 1 hasta 4 átomos de carbono y m y n significan, en suma, 0 o números desde 1 hasta 12 y al menos un compuesto elegido entre el grupo de los glicéridos parciales de los ácidos grasos de la fórmula (IV), en la que R6CO significa un resto acilo lineal o ramificado, saturado y/o insaturado, con 6 hasta 22, R7 y R8 significan, independientemente entre sí, R6CO o H y la suma (a+b+c) significa 0 o números desde 1 hasta 100, con la condición de que, al menos uno de los dos restos R7 y R8 signifique H y los ésteres de sorbitán de la fórmula (V), en la que R9CO significa un resto acilo lineal o ramificado, saturado o insaturado, con 6 hasta 22 y, preferentemente, con 12 hasta 18 átomos de carbono, como antiestáticos internos para materiales sintéticos termoplásticos.
Patent ES-2232462-T3 (ES)
Inventor: POOLE DARRELL MAITLAND
IPC: A61F5/37
Filed: 2000-06-21
Granted: 2005-06-01
Abstract: The invention relates to head or neck supports which support the head or neck in a tilted back position and comprises or includes: a) a harness locatable to the upper body portions of a person, b) a rigid member extending from a region of said harness stabilised in respect of and by the use of the harness relative to the body, wherein, when in use, said harness is attached to the body of a person, said rigid member extending therefrom to provide a support region thereof which when said person is in a substantially upright position, and the head is tilted backwards to allow viewing of an object above the horizontal, said support region comes in contact with at least part of the back of the head and provides at least vertical support to the head.
Patent ES-2204650-T3 (ES)
Inventor: EUTENEUER ARNO
IPC: G01J11/00
Filed: 2000-06-06
Granted: 2004-05-01
Abstract: In a method for influencing and measuring pulsed electromagnetic illumination, e.g. parallel laser light (L), said illumination or light can be spatially divided, in particular, in an autocorrelator comprising a beam receptor (12), can be recombined behind said beam receptor by a superposition or focusing device (18 or 58) and can be detected in the recombinant area by a detector (20). As the transmission system (52), the beam receptor comprises beam profile dividers in a penetrable housing (50), in the form of at least two transmission parts (54; 56), with or in which separate, preferably parallel component beams (S, T) can be modified in their time-based beam characteristics, before being recombined. The inventive beam receptor (12) preferably has at least a two-part mirror (22), plate (32), chamber or crystal system (42) comprising a beam profile divider (14, 24, 34, 44) which creates or leaves unchanged a base component beam (S), whilst the time-based characteristics of this or every other component beam (T) in a neighbouring beam profile divider (16, 26, 36, 46) can be controlled in a different manner, in order to effect, in particular, reflection or transmission delays and/or changes to the optical paths.